Tag: Dr Manish Doshi

Concept Medical Group Hosts CII Southern Gujarat Delegation at Envision Scientific for Study Mission on Manufacturing Innovation Excellence

up18news

Surat (Gujarat) [India], December 30: Concept Medical Group, through its advanced manufacturing arm Envision Scientific Pvt. Ltd., hosted a high-level industry delegation from the Confederation of Indian Industry (CII) as part of a special Study Mission on “Manufacturing Innovation Excellence” at its Surat Special Economic Zone facility. The delegation comprised senior leaders, heads, and directors […]

Continue Reading
Concept

ANVISA Grants Commercial Approval to Concept Medical’s MagicTouch Sirolimus-Coated Balloon for CAD in Brazil

up18news

Revolutionary ANVISA Approval Advances Cardiovascular Treatment in Brazil with Concept Medical’s MagicTouch São Paulo (Brazil), September 17:  Concept Medical Group, a global leader in drug-delivery technologies, announced that ANVISA (Agência Nacional de Vigilância Sanitária), Brazil’s Health Surveillance Agency, has granted commercial approval for its flagship MagicTouch, Sirolimus-Coated Balloon (SCB) for CAD treatment. This milestone enables patients […]

Continue Reading
Concept Medical launches MAGICAL-SV trial for small-vessel coronary treatment - PNN

Concept Medical Enrolls First Patient in MAGICAL-SV IDE Trial, Expands Coronary Program Globally

up18news

Concept Medical initiates MAGICAL-SV IDE trial in the U.S. for its sirolimus-coated balloon, with the first patient enrolled at Mount Sinai. Tampa (Florida) [USA], August 4: Concept Medical Inc., a global pioneer in drug-delivery technologies, today announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions […]

Continue Reading
TRANSFORM II - Global Cardiology Trial Redefining Coronary Care with SCB Technology - PNN News

TRANSFORM II Trial Hits Enrollment Milestone: Redefining Coronary Care with Sirolimus-Coated Balloons

up18news

Roughly 80% of patients undergoing percutaneous coronary interventions (PCI) fall into the vessel size category being studied in TRANSFORM II. New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has successfully finished patient enrolment for TRANSFORM II, one of the most ambitious and extensive randomised controlled trials (RCTs) ever carried out in […]

Continue Reading

Concept Medical Receives Third US FDA’s IDE Approval for Its Magictouch – Sirolimus Coated Balloon in Small Vessel Indication

up18news

Surat (Gujarat) [India], May 1: Concept Medical Inc. (CMI), a global leader in drug delivery devices, has received its third Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for its novel Sirolimus-coated balloon, Magic Touch SCB, for the treatment of Small Vessels (SV) in coronary arteries. This milestone comes after […]

Continue Reading